Smith, David A. http://orcid.org/0000-0001-7778-7137
Fernandez-Antunez, Carlota
Magri, Andrea
Bowden, Rory http://orcid.org/0000-0001-8596-0366
Chaturvedi, Nimisha
Fellay, Jacques http://orcid.org/0000-0002-8240-939X
McLauchlan, John
Foster, Graham R.
Irving, William L.
Ball, Jonathan
Brainard, Diana
Burgess, Gary
Cooke, Graham
Dillon, John
Gore, Charles
Guha, Neil
Halford, Rachel
Herath, Cham
Holmes, Chris
Howe, Anita
Hudson, Emma
Irving, William
Khakoo, Salim
Klenerman, Paul
Koletzki, Diana
Martin, Natasha
Massetto, Benedetta
Mbisa, Tamyo
McHutchison, John
McKeating, Jane
Miners, Alec
Murray, Andrea
Shaw, Peter
Spencer, Chris C. A.
Targett-Adams, Paul
Thomson, Emma
Vickerman, Peter
Zitzmann, Nicole
Simmonds, Peter
Pedergnana, Vincent
Ramirez, Santseharay
Bukh, Jens http://orcid.org/0000-0002-7815-4806
Barnes, Eleanor http://orcid.org/0000-0002-0860-0831
Ansari, M. Azim http://orcid.org/0000-0003-2790-8353
,
Funding for this research was provided by:
Wellcome Trust (220171/Z/20/Z)
Article History
Received: 4 June 2020
Accepted: 11 August 2021
First Online: 20 October 2021
Competing interests
: G.R.F.: Grants Consulting and Speaker/Advisory Board: AbbVie, Alcura, Bristol-Myers Squibb, Gilead, Janssen, GlaxoSmithKline, Merck, Roche, Springbank, Idenix, Tekmira, Novartis. W.L.I.: Grants, Consulting and Advisory/ Speaker Board: Roche, Janssen Cilag, Gilead Sciences, Novartis, GlaxoSmithKline, Pfizer, Abbvie and Bristol-Myers Squibb. All other D.A.S., C.F., A.M., R.B., N.C., J.F., J.M., P.S., V.P., S.R., J.B., E.B., M.A.A. authors have no competing interests to declare.